Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $55.4 million.

  • Treace Medical Concepts' Operating Expenses rose 802.87% to $55.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.3 million, marking a year-over-year decrease of 112.14%. This contributed to the annual value of $224.0 million for FY2024, which is 1012.32% up from last year.
  • Latest data reveals that Treace Medical Concepts reported Operating Expenses of $55.4 million as of Q3 2025, which was up 802.87% from $54.7 million recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Operating Expenses high stood at $59.9 million for Q1 2024, and its period low was $16.8 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $44.2 million, with a median of $47.9 million in 2023.
  • As far as peak fluctuations go, Treace Medical Concepts' Operating Expenses surged by 18947.3% in 2021, and later tumbled by 412.68% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Operating Expenses stood at $33.7 million in 2021, then skyrocketed by 31.42% to $44.2 million in 2022, then skyrocketed by 30.01% to $57.5 million in 2023, then dropped by 3.21% to $55.7 million in 2024, then decreased by 0.54% to $55.4 million in 2025.
  • Its Operating Expenses stands at $55.4 million for Q3 2025, versus $54.7 million for Q2 2025 and $57.5 million for Q1 2025.